Word

EIRGEN

Status

Registered

Status Code

700

Status Date

Tuesday, September 26, 2023

Serial Number

97383276

Registration Number

7172805

Registration Date

Tuesday, September 26, 2023

Mark Type

4000

Filing Date

Tuesday, April 26, 2022

Published for Opposition

Tuesday, July 11, 2023

Trademark Owner History

EirGen Pharma Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of medical ailments and medical conditions, namely, cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders and infectious and non-infectious diseases; sanitary preparations for medical use; prescription pharmaceutical and biotechnological preparations for the treatment of medical ailments and medical conditions, namely, cardiovascular and central nervous system disorders, malignant diseases and immunosuppression musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders and infectious and non-infectious diseases; biological preparations for medical purposes, namely, for use in biotechnology for the treatment of cancer, infectious diseases, metabolic diseases and disorders; chemical preparations and reagents for use in biotechnology for medical and veterinary use, namely, renal diseases and disorders, cognitive and neurological disorders, vitamin D insufficiencies, cancer and infectious diseases; injectable solutions for medical purposes, namely, injectable pharmaceuticals for cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders; dietetic foods, namely, pasta, crackers, and bread, food supplements, infusions, drinks and beverages all adapted for medical use; all purpose disinfectants, oral disinfectants for medical and hygienic purposes, disinfectants for hygienic and sanitary purposes, disinfectants for medical instruments; syrups for pharmaceutical purposes, namely, cough syrups; vaccines; syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders for medical use; pre-filled disposable syringes and hypodermic syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders for medical use

1 Chemicals used in industry, science and photography; chemical substances for preserving foodstuffs; adhesives used in industry; biological preparations for use in biotechnology other than for medical use

42 The provision of information on the subject of research and development, drug development and product evaluation all in the field of pharmaceuticals and biotechnology; scientific and industrial research relating to pharmaceuticals and biotechnology

Trademark Events

Sep 26, 2023

Notice Of Registration Confirmation Emailed

Sep 26, 2023

Registered-Principal Register

Jul 11, 2023

Official Gazette Publication Confirmation E-Mailed

Jul 11, 2023

Published For Opposition

Jun 21, 2023

Notification Of Notice Of Publication E-Mailed

Jun 7, 2023

Electronic Record Review Complete

Jun 2, 2023

On Hold - Electronic Record Review Required

May 30, 2023

Approved For Pub - Principal Register

May 26, 2023

Teas/Email Correspondence Entered

May 25, 2023

Correspondence Received In Law Office

May 25, 2023

Teas Response To Office Action Received

May 15, 2023

Application Extension Granted/Receipt Provided

May 15, 2023

Application Extension To Response Period - Received

Feb 13, 2023

Notification Of Non-Final Action E-Mailed

Feb 13, 2023

Non-Final Action E-Mailed

Feb 13, 2023

Non-Final Action Written

Feb 13, 2023

Assigned To Examiner

May 3, 2022

New Application Office Supplied Data Entered

Apr 29, 2022

New Application Entered